Urate lowering therapy - Open Access .click

Results 161 to 170 of about 2,554,026 (187)

Some of the next articles are maybe not open access.

[Gout: an overview of available urate lowering therapies].

Annales pharmaceutiques francaises, 2012
The aim of urate-lowering therapy is to maintain urate concentration below the saturation point for monosodium urate. This therapy dissolves crystal deposits and cures gout while it is maintained. EULAR guidelines recommend that plasma urate should be maintained at a concentration less than 360μM, and the British Guidelines less than 300μM.
openaire +2 more sources

Influence of urate-lowering therapies on renal handling of uric acid

Clinical Rheumatology, 2014
The purpose of this study is to investigate the effect of urate-lowering therapies (ULTs) on renal uric acid excretion in gout patients. This prospective observational study involved 106 primary gout patients and 51 healthy controls. Gout patients received ULT with either xanthine oxidase inhibitors or the uricosuric agent benzbromarone.
Lili, Ma +6 more
openaire +2 more sources

Urate-Lowering Therapy for the Management of Gout: A Summary of 2 Cochrane Reviews

The Journal of Rheumatology Supplement, 2014
To systematically review the evidence on the efficacy, safety, and cost-effectiveness of urate-lowering therapy for gout: xanthine oxidase inhibitors (allopurinol and febuxostat), uricosuric medications (benzbromarone, probenecid and sulfinpyrazone), and uricases (pegloticase and rasburicase).A systematic review was performed as part of the 3e ...
Kydd, A.S. +6 more
openaire +3 more sources

Response to “Urate lowering therapy for patients with gout on hemodialysis”